Cancers, Vol. 9, Pages 73: Quality-of-Life (QOL) during Screening for Phase 1 Trial Studies in Patients with Advanced Solid Tumors and Its Impact on Risk for Serious Adverse Events

Conclusions: Lower (worse) EORTC QLQ-C30 score at baseline is associated with SAE occurrence during phase 1 oncology trials.

Source: Cancers - June 26, 2017 Category: Cancer & Oncology Authors: Sidra Anwar Wei Tan Chi-Chen Hong Sonal Admane Askia Dozier Francine Siedlecki Amy Whitworth Ann Marie DiRaddo Dawn DePaolo Sandra M. Jacob Wen Wee Ma Austin Miller Alex A. Adjei Grace K. Dy Tags: Article Source Type: research